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More women are delaying childbearing, and the percentage of
women who became pregnant for the first time between the
ages of 35 and 39 increased sixfold between 1973 and 2006.1
There was a fourfold increase for women aged 40 to 44 years.1
Currently, approximately 15% of the pregnant population is
older than 35 years.2 As the risk of trisomy 13 (T13) and
trisomy18 (T18) is age related,morewomenare at riskof being
diagnosed with fetal T13 or T18.3 Over the past 20 years,
prenatal screening and diagnosis have improved dramatically
through such technologies as ultrasound, maternal serum
screening, and cell-free DNA screening.4 Though the overall
incidence of T13 and T18 is low, 1:3,700 for T18 and 1:7,900 for
T13, the rates of these are increasing due to the above factors.3
Outcomes and survival duration for infants born with T13
or T18 vary based on the degree of intervention (INT), as well
as phenotype and genotype of the disorder.5–7 Counseling is
further limited because existing data are often biased toward
non-INT.8–10 Other data about the degree of INTs offered to
and desired by the family are nonspecific. In addition, a







Abstract Objective The objective of this study was to describe antenatal/intrapartum manage-
ment and survival of liveborn infants with known trisomy 13 (T13) or trisomy 18 (T18)
based on planned neonatal care.
Study Design This is a retrospective cohort study of singleton pregnancies complicat-
ed by T13/T18 at a tertiary center from 2004 to 2015. We included pregnancies with
antenatal or neonatal cytogenetic T13/T18 diagnosis and excluded those which were
terminated or had a fetal demise < 20 weeks. We compared antenatal/intrapartum
management and neonatal survival by planned neonatal care, defined as either neonatal
intervention (INT), including neonatal cardiopulmonary resuscitative measures or
comfort care (CC) without resuscitative measures.
Results In this study, 32 women (10 with T13 and 22 with T18) met study criteria; 12
(38%) elected INT and 20 (62%) CC. Compared with those who elected INT, women who
elected CC were more likely to undergo elective induction (40 vs. 0%, p ¼ 0.01), have an
intrapartum stillbirth (0 vs. 32%, p ¼ 0.14), and deliver vaginally (25 vs. 63%, p < 0.01).
In neonatal survival analysis (n ¼ 26), median survival was longer in the INT group
compared with CC group (64 days [interquartile range, IQR: 2, 155) vs. 3 days [IQR]: 0.3,
42), p ¼ 0.28), but survival to hospital discharge was similar (53 vs. 57%, p ¼ 0.95).
Conclusion Regardless of desired level of neonatal INT, many women who continue
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Obstetric providers are further challenged by how to
manage these pregnancies. Fetuses with T13 and T18 are
often growth restricted and are known to be at very high risk
for intrauterine fetal demise.11–13 There are nopublished data
regarding antenatal and intrapartum management strategies
for patients with a pregnancy complicated by T13 or T18.
The aim of this study was to describe antepartum and
intrapartum management strategies for pregnancies compli-
cated by T13 and T18 to providemore information for providers
who are counseling families regarding these specific issues. In
addition, we sought to compare survival duration for infants
based on the degree of INT desired by the family.
Materials and Methods
We performed a retrospective cohort study of singleton
pregnancies complicated by T13 or T18 at a tertiary referral
center between January 2004 and April 2015. Patients were
identified from the institution’s cytogenetic database, the
institution’s perinatal database that catalogues all deliveries,
and from the University of North Carolina Center forMaternal
and Infant Health database. Identified cases were cross-
referenced and duplicates were excluded.
Women with prenatally diagnosed or suspected fetal T13
or T18 who delivered at our institution were included in the
study (n ¼ 27). Infants who delivered at an outside institu-
tion andwere transferred to our institution immediately after
delivery were also included (n ¼ 5). All women had diagnos-
tic cytogenetic testing prenatally or immediately postpartum.
Exclusion criteria included twin pregnancies, those who
elected to terminate the pregnancy, those who experienced
pregnancy loss before 20 weeks, and antepartum stillbirths.
We planned to exclude mosaic infants; however, there were
no cases of mosaicism in this cohort.
For analyses related to antepartum and intrapartum man-
agement, we included patients who had prenatal care and
delivered at our institution (n ¼ 27). For analyses related to
survival, the five infants born at another institution and
transferred to our neonatal intensive care unit immediately
after delivery were included, but the six infants with intra-
partum deaths from our center were not (n ¼ 26). At our
institution, when the diagnosis of T13 or T18 is made or
strongly suspected, the family is given the choice of neonatal
INT or comfort care (CC) at the time of delivery.
Chart review of both maternal and infant’s records was
performed by two physicians, the reviews were then spot
checked by a third physician. Demographic data, ultrasound
results, laboratory findings, counseling encounters, and preg-
nancyanddeliveryoutcomeswere abstracted fromthematernal
medical record. Infant survival and outcome datawere obtained
from the infant’s medical record. Neonatal INT was defined as
any INT in the delivery room or during the delivery admission.
CC14 was defined as parental decision for no delivery room
resuscitation or neonatal procedures (e.g., intubation). Families
whowantedneonatal assessment at birth beforedecidingon INT
or CC (n ¼ 2) were classified based on delivery room decision.
Indication for antenatal testing was defined based on the
indication listed on the visit encounter form and included any
of the following: nonstress test (NST), biophysical profile (BPP),
umbilical artery Doppler studies, or growth ultrasound(s). Not
all charts specified the degree of intrapartum monitoring. Fetal
heart rate tracings were not available for most patients, thus
continuous monitoring versus intermittent monitoring were
determined based on intrapartum documentation.
Bivariate analysis was performed using Student t-test,
Wilcoxon rank sum, and Kruskal–Wallis test for continuous
variables and chi-square or Fisher exact test, as appropriate,
for categorical variables. Antenatal and intrapartummanage-
ment strategies were compared by parental desire for INT.
Kaplan–Meier curves were performed for survival time based
onparental desire for INT for all infants in the cohort aswell as
for T13 and T18 infants separately. Infantswere followed until
death or loss to follow-up; theywere censored once theywere
lost to follow-up for > 12 months. Log-rank tests were used
to compare survival based on degree of INT and data were
analyzed by an intention to treat analysis.
Statistical significance was defined as p < 0.05. Stata 14.0
(StataCorp, College station, TX,) was used to perform the
analysis. This study was approved by the University of North
Carolina Institutional Review Board.
Results
During the 11-year study period, there were 64 cases with a
cytogenetic diagnosis of T13 and 103 with T18. Of the T13
cases, 50 (78%) elected termination and 4 (6%) had an ante-
partum stillbirth and were thus excluded from this analysis.
Among T18 cases, 77 (75%) ended in termination and 4 (4%)
had an antepartum stillbirth. Overall, 10 fetuseswith T13 and
22 fetuses with T18 met inclusion criteria for this analysis. Of
these infants, 12 (38%) parents elected for neonatal INT (T13:
n ¼ 5; T18: n ¼ 7), and 20 (62%) parents planned for CC (T13:
n ¼ 5; T18: n ¼ 15) (►Fig. 1).
Compared with women who desired CC, women who
desired INT were older (38.5 vs. 30.0 years), and a higher
percentagewere primiparous (►Table 1). No differenceswere
observed by race/ethnicity, marital status, insurance status,
and medical comorbidities. Women who selected INT
were less likely to have a genetic counselor for a consultation
(42 vs. 85%) and less likely to have a prenatal diagnostic
procedure such as amniocentesis or chorionic villous sam-
pling (8.3 vs. 90%).
When considering antenatal and delivery management,
only 27 women who had prenatal care and delivered at our
institution were included in the analysis. Of those women, 19
elected CC and 8 desired INT. All women had a targeted
anatomy ultrasound, all of which were abnormal. Most
women (89%) had a maternal–fetal medicine consult
(►Table 2). Over half of the women who desired CC had
some form of antenatal testing; of these, more than 20% had
BPPs and almost half had at least one ultrasound for fetal
growth. In contrast, among those desiring INT, 88% had at
least one form of antenatal testing, 63% had NSTs, 38% had
BPPs, and 88% had at least one growth ultrasound.
The median gestational age at delivery did not differ by
desired INT (►Table 3). With regard to intrapartum fetal
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monitoring, all women in the INT group and half of the
women in the CC cohort had at least some form of monitoring
(ranging from intermittent to continuous). There were six
intrapartum deaths in the CC group: two who had intermit-
tentmonitoring and four where the degree ofmonitoringwas
not specified. Therewere no stillbirths in the INT group.Mode
of delivery was different between the two groups. In the CC
group, 89.5% of women delivered vaginally, with five of those
being breech vaginal deliveries. In the CC group, there was
one cesarean delivery for breech presentation and one for a






Median maternal age (IQR) 38.5 (32.5, 42.5) 30 (26.5, 36.5) 0.08
Insurance status (%)
Private 7 (58) 6 (30) 0.31
Medicaid 2 (17) 7 (35)
Self-pay 3 (25) 7 (35)
Race (%)
White 3 (25) 7 (35) 0.40
Black 5 (42) 3 (15)
Hispanic 4 (33) 9 (45)
Other 0 1 (3)
Married (%)a 9 (90) 16 (89) > 0.99
Primiparous (%) 4 (33) 1 (5) 0.05
History of preterm delivery (%) 1 (8) 0 0.39
Any medical comorbidity (%)b 3 (25) 2 (10) 0.34
Prenatal diagnosis (%)c 1 (8) 18 (90) < 0.001
Genetic counseling (%) 5 (42) 17 (85) 0.02
Abbreviations: IQR, interquartile range; T13, trisomy 13; T18, trisomy 18.
aData only available for marital status on 28 women.
bMedical issues included: type 1 or type 2 diabetes, chronic hypertension, or asthma.
cIncludes amniocentesis or chorionic villus sampling.
Table 2 Antepartummanagement strategies for women with a
pregnancy complicated by T13 or T18 (N ¼ 27), 2004–2015
Intervention
n ¼ 8 (%)
Comfort care




6 (75) 18 (95) 0.20
Had neonatology
consult
2 (25) 10 (53) 0.24
Any antenatal
testinga
7 (88) 10 (53) 0.19
Nonstress test 5 (63) 2 (11) 0.01
Biophysical
profile
3 (38) 4 (21) 0.63
Umbilical artery
Doppler
2 (25) 2 (11) 0.56
Growth
ultrasound
7 (88) 9 (47) 0.09
Abbreviations: T13, trisomy 13; T18, trisomy 18.
aIncludes nonstress test, biophysical profile, umbilical artery Doppler, or
growth ultrasound.
Cytogenec diagnosis of  T13 or T18
(n = 167, T13 = 64 and T18 = 103)
Elected to connue the pregnancy
(n = 40, T13 = 14 and T18 = 26)
Presented with a live fetus for delivery*
(n = 32, T13 = 10 and T18 = 22)
Excluded:
-Elected terminaon (n = 127,
T13 = 50 and T18 = 77)
Neonatal intervenon
(n = 12, T13 = 5 and
T18 = 7) 
Comfort care
(n = 14, T13 = 5 and T18 = 9)
Antepartum demise
(n = 8, T13 = 4 and T18 = 4) 
Intrapartum demise
(n= 6, T13 = 0 and T18 = 6) 
Liveborn a
(n= 26, T13 = 10 and T18 = 16)
Fig. 1 Study population. Flow diagram documenting inclusion and
exclusion criteria. This figure illustrates how patients came to be included in
the study. The “” refers to the fact of the 32 infants who survived to
delivery, 5 infants were outborn, thus we did not have documentation
antepartum or intrapartum monitoring. Therefore, only 27 infants were
included in the antepartum and intrapartum analysis. The “a” denotes that
only liveborn infants were included in the survival analysis.
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history of a prior cesarean delivery. In contrast, 75% of women
in the INT group were delivered by cesarean. Indications for
cesarean delivery included: nonreassuring fetal status
(n ¼ 2), arrest of dilation (n ¼ 1), breech presentation
(n ¼ 1), prior cesarean (n ¼ 1), and elective primary (n ¼ 1).
Of the 32 women who presented with a live fetus for
delivery, 6 (19%) infants (all with T18) had intrapartum
demise. Of those born alive (n ¼ 26), 12 had neonatal INT
(T13: n ¼ 5; T18: n ¼ 7) and 14 had CC (T13: n ¼ 5; T18:
n ¼ 9) (►Table 4). All infants survived at least 1 hour; 11/12 in






Median GA at delivery (IQR) 37 (33.1, 38.1) 38 (35.6, 39.6) 0.17
Elective induction (%) 0 8 (40) 0.01
Any monitoring (%) 8 (100) 10 (53) 0.06
Continuous monitoringa (%) 5/7 (71) 4/10 (40) 0.07
Stillborn (%) 0 6 (32) 0.14
Mode of delivery (%)
Vaginal delivery 2 (25) 12 (63) 0.003
Breech vaginal delivery 0 5 (26)
Cesarean delivery 6 (75) 2 (11)
Abbreviations: GA, gestational age; IQR, interquartile range; T13, trisomy 13; T18, trisomy 18.
aThe degree of monitoring was only documented in 17 cases: 7 in the intervention group and 10 in the comfort care group.
Table 4 Neonatal survival among infants with T13 or T18 (N ¼ 26), 2004–2015
Intervention Comfort care p-Value
All patients: T13 or T18 (n ¼ 26)
1 ha (%) 12/12 (100) 14/14 (100) > 0.99
1 da (%) 11/12 (92) 9/14 (64) 0.17
1 wka (%) 9/12 (75) 5/14 (36) 0.045
1 moa (%) 5/10 (50) 4/14 (29) 0.68
1 ya (%) 1/9 (11) 2/12 (8.3) > 0.99
Median survival (IQR) 64 (2, 155) 3 (0.5, 42) 0.28
Survival at hospital discharge (%) 7 (58) 8 (5) > 0.99
T13 (n ¼ 10)
1 ha (%) 5/5 (100) 5/5 (100) > 0.99
1 da (%) 5/5 (100) 2/5 (40) 0.17
1 wka (%) 3/5 (60) 1/5 (20) 0.59
1 moa (%) 1/4 (25) 1/5 (20) > 0.99
1 ya (%) 1/4 (25) 0/4 (0) > 0.99
Median survival (IQR) 7.3 (4, 14) 0.5 (0.04, 2) 0.20
Survival at hospital discharge (%) 2 (40) 1 (20) > 0.99
T18 (n ¼ 16)
1 ha (%) 7/7 (100) 9/9 (100) > 0.99
1 da (%) 6/7 (86) 7/9 (78) > 0.99
1 wka (%) 6/7 (86) 4/9 (44) 0.15
1 moa (%) 4/6 (66) 3/9 (33) 0.62
1 ya (%) 0/5 (0) 2/8 (25) 0.48
Median survival (IQR) 150 (19, 155) 22 (3, 40) 0.85
Survival at hospital discharge (%) 5 (71) 7 (78) > 0.99
Abbreviations: IQR, interquartile range; T13, trisomy 13; T18, trisomy 18.
aDenominators denote number of known survivors while accounting for lost to follow-up.
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the INT group and 9/14 in the CC group survived at least 1 day
and more than half of the infants in each group survived to
hospital discharge. For infants receiving INT, median survival
time after delivery was 64 days as compared with 3 days for
those getting CC (p ¼ 0.28) (►Figs. 2 and 3).
Comment
This study revealed that women with a pregnancy compli-
cated by T13 or T18 who were planning for neonatal INT at
delivery hadmore antenatal testing than those planning for
CC, although a large percentage of those planning for CC
also had antenatal testing. A surprisingly large number of
women in the CC group had continuous monitoring during
labor. The mode of delivery was dramatically different
between the two groups, with almost all CC fetuses deliv-
ering vaginally, even when they were in the breech presen-
tation. Importantly, more than half of the infants in the CC
group survived to hospital discharge. Based on this sample,
infants with T13 or T18who received neonatal INT survived
longer.
There is a paucity of data regarding antepartum and
intrapartum management of women with fetal T13 or T18.
Due to the high rate of associated fetal anomalies and
growth restriction, the issue of antenatal testing often
arises for infants with T13 and T18. We were unable to
identify any other published literature describing the use of
antenatal testing in these fetuses. An unexpected finding
was the significant rate of fetal testing among families who
were planning for CC. This testing was partly driven by
growth ultrasounds, which also provided the family an
opportunity to see the fetus additional times before
delivery.
Intrapartum monitoring in the setting of a known diag-
nosis of T13 or T18 is also not well described in the
literature. Cesarean delivery for fetal distress occurs
frequently among infants where the diagnosis of T18 is
unknown or suspected prenatally.15–17 Subramaniam et al
estimated cesarean delivery rates of 42% for prenatally
diagnosed and 69% for postnatally diagnosed T18 infants.7
Similar to our findings, other studies also suggest a high
cesarean rate (> 50%), even in the setting of knownT18.18,19
Interestingly, cesarean delivery rates appear to be lower
among T13 fetuses in these prior studies.15,20 In the present
study, we found cesarean delivery rates to be markedly
higher for patients who desired neonatal INT when com-
pared with those who desired only CC. Another significant
finding in our study was the use of breech vaginal delivery
to avoid cesarean delivery in women who desired CC only.
When a provider is comfortable with breech deliveries, this
should be considered over cesarean for women with a
breech fetus with T13 or T18.
Many authors have described the natural history of T18.
Recently, two large series includingmore than 1,100 infants
with T18 described median survival of 7 to 8 days.21,22
These same studies examined similar outcomes for more
than 800 infants with T13 and found median survival of
4.5 to 5 days.21,22 However, as these were both population-
based studies, the degree of neonatal INT was unable to be
assessed. The question of the effects of aggressive com-
pared with nonaggressive neonatal INT on survival was
recently addressed by Subramaniam et al for neonates with
T18.7 In that cohort of 46 infants with full T18, there were
only 4 who had CC, compared with 42 who had any INT (of
Fig. 2 Survival in liveborn T13/T18 based on type of care provided at
delivery and in first 48 hours of life (n ¼ 26) 2004 to 2015. Kaplan–Meier
curves showing survival stratified by CC (n ¼ 14) compared with neonatal
INT (n ¼ 12). This figure compares neonatal survival for infants with T13 or
T18 based on the degree of INT offered in the delivery room and first 48
hours of life. For those lost to follow-up, survival time was censored at the
last documented time alive. There was no difference between the groups
based on degree of INT. The “” denotes 180 days of survival, a cutoff that
was used to better accentuate early death. There was one alive at 180 days
in the INT group and two in the CC group. Median survival time is listed in
days, within the parenthesis is survival range, then interquartile range for
survival denoted by Q1 to Q3. CC, comfort care; INT, intervention.
Fig. 3 Trisomy-specific survival by one type of care provided at delivery and
in first 48hours of life (n ¼ 26) 2004 to2015. Kaplan–Meier curves showing
survival stratified by T13 or T18, comparing INT to CC. This figure compares
neonatal survival by trisomy type for infants based on the degree of INT
offered in the delivery room and first 48 hours of life. For those lost to
follow-up, survival time was censored at the last known time alive. There
was no difference between the groups based on degree of INT. The “”
denotes 180 days of survival, a cutoff that was used to better accentuate
early death. There was one alive at 180 days in the T13 INT group and two in
the T18 CC group. Median survival time is listed in days, within the
parenthesis is survival range, then interquartile range for survival denoted
by Q1 to Q3. CC, comfort care; INT, intervention.
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those 31 had aggressive INT and 11 had nonaggressive INT).
When comparing the two INT groups, there was no differ-
ence in median survival. Given the small number of infants
who did not receive any INT, that group was not analyzed
independently and was excluded from the analysis. How-
ever, similar to our study, the authors found that long-term
survival was rare, with only two living more than 1 year.7 It
should be noted that for one of the infants in the CC group,
after surviving for more than 2months at home, the parents
requested pediatric INTs. This infant was included in the CC
group based on our intention to treat analysis. However,
the outcomes at more than 2 months could be due to INT.
Our study is the first to specifically compare CC only with
neonatal INT with respect to neonatal survival. Providers
often counsel patients that duration of survival is short for
these infants. One original finding in this study was that even
with CC, over half of the infants survived to go home with
their families. This raises an important issuewhen counseling
families and when caring for families after delivery. Setting
the expectation that their infant may go homewith them and
may die at home is important. Ensuring that the appropriate
resources (such as neonatal hospice) exist and are in place
before discharge to help a family in this situation is essential.
To accurately counsel a family with fetal T13 or T18, an
understanding of survival duration based on degree of INT
is important.
This study is limited by a small sample size, and thusmay
not be powered to show differences in outcomes. The data
are also from a single center, and provider attitudes may be
biased. However, due to the long time period over which
data were collected, there were several providers with
varying attitudes toward management of these pregnan-
cies, limiting this bias. Since this is a tertiary referral center,
we were also limited in that some patients traveled far
to deliver and many of them were lost to follow-up
after discharge. Finally, due to the retrospective nature
of the study, not all data points were available for all
subjects.
Despite these limitations, this study adds to the litera-
ture regarding antepartum and intrapartum management
of T13 and T18. The realization that many families who
desire CC at delivery are concerned regarding fetal well-
being in utero and thus may receive antenatal testing is
important for providers to consider. These concerns may
extend to a desire for intrapartum monitoring for patients
who desire CC as well. Many neonates only receiving CC
survive to leave the hospital with their family and may
survive for days to weeks or longer. All of these details are
important to consider when counseling at the time of
diagnosis and during prenatal care for women who contin-
ue to the pregnancy.
Note
Thismaterial was presented in poster format at the Society
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